SCHEMBL18149341

SCHEMBL18149341

Cn1[nH]c2cc(Cl)ccc2c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.56
CA9 Q16790 2/20 0.51
CA12 O43570 1/20 0.51
TP53 P04637 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
DAO P14920 1/20 0.47
LMNA P02545 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MPO P05164 1/20 0.45
XDH P47989 1/20 0.45
TSHR P16473 1/20 0.45
PARP1 P09874 1/20 0.44
CMA1 P23946 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4E B2RXH2 1/20 0.43
F11 P03951 1/20 0.42
KLKB1 P03952 1/20 0.42
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18149140 0.79 ALOX5 (0.58) ALOX5CA9CA12TP53SMN1; SMN2
SCHEMBL18327471 0.79 ALOX5 (0.58) ALOX5TP53DAOLMNAALDH1A1
SCHEMBL25410748 0.78 CA9 (0.49) CA9CA12DAOALDH1A1MPO
SCHEMBL9919009 0.75 CA9 (0.66) CA9CA12TP53SMN1; SMN2DAO
SCHEMBL18149298 0.75 ALOX5 (0.45) ALOX5TP53LMNAMEN1KMT2A
SCHEMBL18164723 0.74 ALOX5 (0.51) ALOX5TP53DAOPARP1KDM4E
SCHEMBL2671133 0.74 KDM4E (0.52) ALOX5SMN1; SMN2ALDH1A1PARP1KMT2A
SCHEMBL4402967 0.74 ALOX5 (0.51) ALOX5TP53SMN1; SMN2LMNAALDH1A1
SCHEMBL9646339 0.74 ALOX5 (0.51) ALOX5GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL25410120 0.74 CA9 (0.44) CA9CA12TP53SMN1; SMN2DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10160748-B2 Indazolones as modulators of tnf signaling ABBVIE INC. (US) 2018-12-25 US disclosed
US-20180086737-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING ABBVIE INC. 2018-03-29 US disclosed
US-20180086737-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING ABBVIE INC. 2018-03-29 US disclosed
US-20180086737-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING ABBVIE INC. 2018-03-29 US disclosed
EP-3294726-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING AbbVie Inc. (US) 2018-03-21 EP disclosed
US-20160304496-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING ABBVIE INC. 2016-10-20 US disclosed
US-20160304496-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING ABBVIE INC. 2016-10-20 US disclosed
WO-2016168633-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING ABBVIE INC. (US) 2016-10-20 WO disclosed
WO-2016168633-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING ABBVIE INC. (US) 2016-10-20 WO disclosed
US-20160304496-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING ABBVIE INC. 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304496-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING TNF, CD40, TNFRSF1A ALOX5 1072/4885CA9 4729/4885CA12 4828/4885
US-20180086737-A1 INDAZOLONES AS MODULATORS OF TNF SIGNALING TNF, CD40, TNFRSF1A ALOX5 1072/4885CA9 4729/4885CA12 4828/4885
US-10160748-B2 Indazolones as modulators of tnf signaling TNF, CD40, TNFRSF1A ALOX5 1072/4885CA9 4729/4885CA12 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.